• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性转移性骨巨细胞瘤的化疗:1例罕见病例报告及联合化疗反应

Chemotherapy of a malignant, metastasizing giant-cell tumor of bone: report of an unusual case and the response to combination chemotherapy.

作者信息

Mella O, Dahl O, Bang G, Engedal H, Gøthlin J, Lunde O D

出版信息

Cancer. 1982 Jul 15;50(2):207-11. doi: 10.1002/1097-0142(19820715)50:2<207::aid-cncr2820500206>3.0.co;2-n.

DOI:10.1002/1097-0142(19820715)50:2<207::aid-cncr2820500206>3.0.co;2-n
PMID:6979381
Abstract

A 13-year-old girl was treated surgically for a giant-cell tumor of bone originating in the talus and for a recurrence in the distal tibia. She later developed liver and lung metastases and was treated for two years, five months with a combination of vincristine, doxorubicin, cyclophosphamide and actinomycin-D, and thereafter with high-dose methotrexate/vincristine with citrovorum factor rescue. A good response was obtained and the patient is without evidence of disease 12 months after a salvage thoracotomy for residual disease in the left lung. Aspects of this singular case are discussed.

摘要

一名13岁女孩接受了手术治疗,以切除起源于距骨的骨巨细胞瘤及胫骨远端的复发病灶。她后来出现了肝肺转移,并接受了两年零五个月的联合化疗,使用药物包括长春新碱、阿霉素、环磷酰胺和放线菌素-D,之后采用大剂量甲氨蝶呤/长春新碱并辅以亚叶酸钙解救治疗。治疗取得了良好效果,在因左肺残留病灶行挽救性开胸手术后12个月,患者无疾病迹象。本文讨论了这一特殊病例的相关情况。

相似文献

1
Chemotherapy of a malignant, metastasizing giant-cell tumor of bone: report of an unusual case and the response to combination chemotherapy.恶性转移性骨巨细胞瘤的化疗:1例罕见病例报告及联合化疗反应
Cancer. 1982 Jul 15;50(2):207-11. doi: 10.1002/1097-0142(19820715)50:2<207::aid-cncr2820500206>3.0.co;2-n.
2
Selected applications of methotrexate alone and in combination in osteosarcoma.
Cancer Treat Rep. 1981;65 Suppl 1:107-11.
3
Age and dose of chemotherapy as major prognostic factors in a trial of adjuvant therapy of osteosarcoma combining two alternating drug combinations and early prophylactic lung irradiation. French Bone Tumor Study Group.在一项骨肉瘤辅助治疗试验中,化疗的年龄和剂量作为主要预后因素,该试验联合两种交替使用的药物组合及早期预防性肺部放疗。法国骨肿瘤研究组。
Cancer. 1988 Apr 1;61(7):1304-11. doi: 10.1002/1097-0142(19880401)61:7<1304::aid-cncr2820610705>3.0.co;2-i.
4
Adjuvant chemotherapy of malignant fibrous histiocytoma of bone.
Cancer. 1983 Jan 1;51(1):25-9. doi: 10.1002/1097-0142(19830101)51:1<25::aid-cncr2820510107>3.0.co;2-w.
5
Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).原发性骨肉瘤对术前化疗(大剂量甲氨蝶呤加亚叶酸)反应的预后因素
Natl Cancer Inst Monogr. 1981 Apr(56):221-6.
6
Adjuvant chemotherapy for osteosarcoma: a decade of experience.
Surg Clin North Am. 1981 Dec;61(6):1379-89. doi: 10.1016/s0039-6109(16)42592-2.
7
[Alternative chemotherapy of malignant bone neoplasms in children].[儿童恶性骨肿瘤的替代化疗]
Probl Med Wieku Rozwoj. 1990;16:55-68.
8
Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.原发性骨肉瘤:术前化疗及延迟手术的理论依据
Cancer. 1979 Jun;43(6):2163-77. doi: 10.1002/1097-0142(197906)43:6<2163::aid-cncr2820430602>3.0.co;2-s.
9
High-dose methotrexate with leucovorin rescue plus vincristine in advanced sarcoma: a Southwest Oncology Group study.
Cancer Treat Rep. 1984 Feb;68(2):409-10.
10
Pathologic aspects of chemotherapy response in the treatment of osteogenic sarcoma. An analysis of two cases.骨肉瘤治疗中化疗反应的病理学方面。两例分析。
Oncology. 1977;34(6):273-80. doi: 10.1159/000225241.

引用本文的文献

1
An Unusual Presentation of Giant Cell Tumour of Bone in the Talus: A Case Report and Literature Review.距骨骨巨细胞瘤的罕见表现:一例报告及文献复习
Cureus. 2023 Jul 19;15(7):e42138. doi: 10.7759/cureus.42138. eCollection 2023 Jul.
2
Multicentric Giant Cell Tumor of Bone: Metachronous Presentation-a Case Report.骨多中心巨细胞瘤:异时性表现——病例报告
Indian J Surg Oncol. 2021 Dec;12(Suppl 2):332-337. doi: 10.1007/s13193-021-01331-7. Epub 2021 May 17.
3
Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone.
地诺单抗在骨巨细胞瘤治疗中的现状与待解问题
Clin Sarcoma Res. 2016 Sep 14;6(1):15. doi: 10.1186/s13569-016-0056-0. eCollection 2016.
4
Systemic therapy for selected skull base sarcomas: Chondrosarcoma, chordoma, giant cell tumour and solitary fibrous tumour/hemangiopericytoma.特定颅底肉瘤的全身治疗:软骨肉瘤、脊索瘤、骨巨细胞瘤和孤立性纤维性肿瘤/血管外皮细胞瘤。
Rep Pract Oncol Radiother. 2016 Jul-Aug;21(4):361-9. doi: 10.1016/j.rpor.2015.12.005. Epub 2016 Jan 13.